NEW YORKAn innovative clinical trial to be conducted at
Columbia University is now recruiting patients with advanced
pancreatic cancer. The patients will test the effectiveness of the
Gonzalez regimen, which combines a strict diet of fresh
fruits, vegetable juices, dietary supplements, and pancreatic enzyme
extracts with a detoxification program. John Chabot, MD,
a surgical oncologist at Columbia, is the principal investigator.
The researchers are seeking 72 to 90 patients with advanced
pancreatic cancer for the phase III randomized study, which is being
sponsored by the NCIs Office of Cancer Complementary and
Alternative Medicine. Half of the patients will receive standard
therapy with gemcitabine (Gemzar), while the other half will be
assigned to the Gonzalez regimen, developed by Nicholas Gonzalez, MD,
a New York endocrinologist.
For information about patient entry to the trial, contact Michelle
Gabay, RN, at Columbia Presbyterian Cancer Center (221-305-9468).